A Contrast-Dye Iodine Load and a Thyroid That Might Not Handle It Quietly
A man with a known multinodular goiter needs an urgent contrast CT. The disagreement is whether the iodine load he's about to receive is routine, or worth pre-treating for in a gland that has its own real reason to react to it.
Rutherford K., a 74-year-old retired ship's engineer, arrived in the emergency department with acute abdominal pain now strongly suspected to be a bowel obstruction, and the surgical team wants a contrast CT within the hour to plan for likely urgent surgery. His chart notes a multinodular goiter followed by imaging alone for the past six years, never biopsied or treated, with normal thyroid function documented at his last endocrinology visit eight months ago. He has never had an episode of thyrotoxicosis and takes no thyroid medication. Nobody on the surgical team had reason to think about his thyroid until the on-call radiologist, reviewing his chart before administering contrast, flagged it and paused the order.
Iodinated contrast delivers a large iodine load, and what a thyroid gland does with that load depends heavily on what the gland was already like beforehand. In a normal thyroid, the Wolff-Chaikoff effect transiently suppresses hormone synthesis and then escapes back to normal function within days, uneventfully. In a gland with autonomous nodules — exactly what a longstanding multinodular goiter often represents, whether or not it has ever declared itself biochemically — that suppression can fail to take hold properly, and the iodine instead becomes substrate for a surge in hormone production from tissue that was never under normal regulatory control to begin with: iodine-induced thyrotoxicosis, sometimes called the Jod-Basedow phenomenon. This isn't a universal risk from contrast, and most patients with incidentally noted nodules tolerate it without any issue at all — but a longstanding, untreated multinodular goiter in an older patient is closer to the recognized higher-risk picture than a young patient with a normal gland getting routine contrast, and his surgery cannot simply wait for that distinction to be worked out at leisure.
Deciding whether to delay imaging for thyroid prophylaxis
I'd give a dose of methimazole now, before contrast, if it can go in without meaningfully delaying the scan. His longstanding multinodular goiter is exactly the substrate iodine-induced thyrotoxicosis is described in, and and Lee and colleagues' review of contrast-induced thyroid dysfunction describes pre-treatment as a real if thinly-evidenced mitigation strategy in higher-risk patients receiving a large iodine load — a single oral dose doesn't have to cost him significant time.
I need to be direct about the time pressure here: if he has a true surgical obstruction, delay itself carries real risk — bowel ischemia doesn't wait for a thyroid pre-treatment dose to take effect. I don't want a theoretical thyroid risk to meaningfully push back a scan that's driving whether he goes to the operating room tonight.
You're describing this as low-cost, but "give it now" isn't actually zero delay in a patient this acute — every additional step before the scan is a real cost in a situation where minutes plausibly matter, and iodine-induced thyrotoxicosis, when it happens at all, doesn't declare itself for days, well after tonight's actual surgical decision will already be made.
I'd resolve this by not treating them as competing priorities. Proceed with the contrast CT now, without delay, since his surgical timeline genuinely can't absorb even a brief pause — and separately, send a TSH and free T4 today so we have a real baseline on record, plus a note in his chart flagging him for thyroid function monitoring over the coming one to two weeks, when iodine-induced thyrotoxicosis would actually be expected to show up if it's going to. The prophylaxis question and the imaging timeline don't have to be resolved by the same decision.
Agreed: proceed with contrast CT immediately for surgical planning, send baseline thyroid labs today, and flag him for thyroid function monitoring over the following one to two weeks rather than attempting pre-treatment tonight.
Not agreed: whether this specific case should change practice for the next similar patient with more lead time. The endocrinologist would pre-treat a similarly high-risk patient given even a few hours' notice, seeing tonight's decision as time-constrained rather than a statement that prophylaxis isn't worthwhile; the surgeon remains skeptical that a single pre-treatment dose meaningfully changes outcomes given the delayed onset of the risk itself, regardless of how much lead time is available.